Skip to main content
Livermore
Livermore
ZHEN

TD Private Client Wealth LLC

SEC CIK
0001551017
Latest filing
Aug 4, 2026

GSK holding history

GSK plc in every 13F filed by TD Private Client Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
9,645
Value
$505.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by TD Private Client Wealth LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,645$505.6K<0.1%−3,065−24.1%ReducedHolders
Q1 202612,710$701.5K<0.1%−58,077−82.0%ReducedHolders
Q4 202570,787$3.47M0.1%−16,404−18.8%ReducedHolders
Q3 202587,191$3.76M0.1%+9,172+11.8%AddedHolders
Q2 202578,019$3.00M0.1%+70,910+997.5%AddedHolders
Q1 20257,109$275.4K<0.1%+4,383+160.8%AddedHolders
Q4 20242,726$92.2K<0.1%−9,696−78.1%ReducedHolders
Q3 202412,422$507.8K<0.1%+3,346+36.9%AddedHolders
Q2 20249,076$349.4K<0.1%+26+0.3%AddedHolders
Q1 20249,050$388.0K<0.1%+1,768+24.3%AddedHolders
Q4 20237,282$269.9K<0.1%−159−2.1%ReducedHolders
Q3 20237,441$269.7K<0.1%−5,735−43.5%ReducedHolders
Q2 202313,176$469.6K<0.1%+4,071+44.7%AddedHolders
Q1 20239,105$324.0K<0.1%+6,796+294.3%AddedHolders
Q4 20222,309$81.1K<0.1%−14,111−85.9%ReducedHolders
Q3 202216,420$483.2K<0.1%−2,666−14.0%ReducedHolders
Q2 202219,086$830.8K<0.1%+1,303+7.3%AddedHolders
Q1 202217,783$774.6K<0.1%+6,112+52.4%AddedHolders
Q4 202111,671$514.7K<0.1%+4,388+60.2%AddedHolders
Q3 20217,283$278.3K<0.1%−1,869−20.4%ReducedHolders
Q2 20219,152$364.4K<0.1%−1,831−16.7%ReducedHolders
Q1 202110,983$392.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.